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(57) ABSTRACT 
A full-length transcript promoter from mirabilis mosaic 
caulimovirus (MMV) is identi?ed and its DNA sequence 
given. The promoter functions as a strong and uniform 
promoter for chimeric genes inserted into plant cells. This 
strong promoter function is exhibited by histochemical assay 
in seeds and ?oral organs and by reproductive scores of 
transgenic plants including the promoter. The promoter 
preferably includes a 3‘ untranslated region that may be from 
the MMV itself or from a heterologous source With respect 
to the promoter. The promoter is used in a chimeric gene and 
in methods for transforming plant cells to obtain transgenic 
plants, plant tissues, plant cells and seeds incorporating the 
MMV promoter. The MMV FLT promoter shoWs greater 
activity (14 to 24 fold) than the CaMV 35S promoter. A 
modi?ed MMV FLt promoter With duplicated enhancer 
domains shoWs greater activity (3 fold) than With a single 
enhancer domain. 
4 Claims, 11 Drawing Sheets 
(2 of 11 Drawing Sheet(s) Filed in Color) 
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USE OF THE FULL LENGTH TRANSCRIPT 
(FLT) FROM MIRABILIS MOSAIC 
CAULIMOVIRUS TO EXPRESS CHIMERIC 
GENES IN PLANTS 
TECHNICAL FIELD 
The present invention generally relates to a full length 
transcript promoter (FLt) sequence from mirabilis mosaic 
caulimovirus (MMV) and the use thereof to express chi 
meric genes in plant cells and plants. More particularly, the 
present invention relates to the use of Wild type and modi?ed 
MMV FLt DNA sequences, or multiple enhancer domains of 
the MMV FLt DNA sequences, to provide strong promoter 
activity to direct foreign gene expression in transgenic 
plants; a chimeric gene construct containing the MMV FLt 
DNA sequence (or multiple enhancer domains of the MMV 
FLt DNA sequence) and a coding sequence for a protein of 
interest; an expression vector containing the chimeric gene 
construct; a plant cell transformed With the chimeric gene 
construct; a plant seed transformed With the chimeric gene 
construct; a plant tissue transformed With the chimeric gene 
construct; and a transgenic plant transformed With the chi 
meric gene construct. 
BACKGROUND ART 
The Caulimoviruses and their Promoters for Plant Genetic 
Engineering 
For plant genetic engineering applications, a number of 
strong, constitutive promoters have been derived from the 
genome of tWo pararetrovirus subgroups namely caulimovi 
rus (Odell et al., 1985; HasegaWa et al., 1989; Sanger et al., 
1990; Verdaguer et al., 1996; Maiti et al., 1997; Maiti and 
Shepherd, 1998) and badnavirus (Medberry et al., 1992; 
Bhattacharyya-Pakrassi et al., 1993). The caulimoviruses are 
a group of small circular DNA virus of approximately 8 kb 
pairs containing 6 to 8 open reading frames (ORFs). The 
cauli?ower mosaic virus (CaMV) is one of the best charac 
teriZed members of this group. Generally, tWo major tran 
script promoters are present in the caulimovirus genome: 
one is the pregenomic full-length transcript (similar to 
CaMV 35S transcript), Which encompasses the Whole 
genome and the other is the subgenomic transcript (similar 
to CaMV 19S transcript), Which spans only gene VI region 
of caulimovirus. (Odell et al., 1981; HasegaWa et al., 1989; 
Driesen et al., 1993). In infected plants, the full-length 
transcripts (FLts) function both as mRNAs for synthesis of 
viral proteins and as templates during reverse-transcriptase 
mediated replication of viral genome (Guilley et al., 1982; 
Hull and Covey, 1983; Pfeiffer and Hohn, 1983). Transcrip 
tional activity of the CaMV 35S promoter is the result of the 
combinatorial and synergistic interaction of different cis 
elements present in the promoter sequence and the transact 
ing nuclear binding protein factors (Benfey and Chua, 1990; 
Benfey et al., 1990a; 1990b; Fang et al., 1989). 
The CaMV 35S promoter is a Well-characterized strong 
constitutive promoter (Fang et al., 1989; Odell et al., 1985; 
OW et al., 1987; Benfey et al., 1989, 1990; 1990a; 1990b; 
Lam, 1994) that has been extensively used for expressing 
foreign genes in monocotyledonous and dicotyledonous 
plants (Holtrof et al., 1995; Mitsuhara et al., 1996; Wilmink 
et al., 1995). The 35S promoter from CaMV is also active in 
microbes (Assaad and Singer, 1990; Pobjecky et al., 1990) 
and in animal cells (Zahm et al., 1989; Ballas et al., 1989). 
It has been found that single or multiple copies of 
enhancer sequences from the CaMV 35S promoter can 
increase homologous and heterologous promoter expression 
in an orientation-independent manner (OW et al., 1987; Kay 
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et al., 1987; Omirulleh et al., 1993). Similar observation Was 
made When single or multiple copies of the enhancer 
sequence are inserted upstream of the TATA-box of the 
CaMV 19S promoter (OW et al., 1987; Driesen et al., 1993), 
rbcS-3A promoter (Fang et al., 1989) and the nos promoter 
(Odell et al., 1985). The duplication of enhancer sequences 
of FMV FLt-promoter (Maiti et al., 1997) and PC1SV-FLt 
promoter (Maiti and Shepherd, 1998) also increase promoter 
activity. 
Badnavirus, a subgroup of pararetrovirus, infects only 
monocotyledonous plants Whereas caulimovirus infects 
dicotyledonous plants. Promoters from badnavirus like 
Commelana yelloW mottle virus (CYMV) and rice tungro 
bacilliform virus (RTBV) are reported to be primarily active 
in vascular tissue (Bhattacharyya-Pakrasi et al., 1993; Med 
berry et al., 1992; Yin and Beachy, 1995). 
The genomes of several caulimoviruses including CaMV 
(Gardner et al., 1981), carnation etched ring virus (CERV), 
(Hull et al., 1986), ?gWort mosaic virus (FMV), (Richins, 
1987), soybean chlorotic mottle virus (SoCMV), (HasegaWa 
et al., 1989), peanut chlorotic streak virus (PC1SV), 
(Richins, 1993), cassava vein mosaic virus (CVMV), 
(Calvert et al., 1995), straWberry vein banding virus 
(SVBV), (PetrZik, 1996), and petunia vein clearing virus 
(PVCV), (Richert-Poggler and Shepherd, 1997) have been 
fully sequenced. 
A number of transcriptional promoters have been derived 
from the genomes of pararetroviruses: for example the rice 
tungro bacilliform virus (RTBV), (Bhattacharyya-Pakrasi et 
al., 1993), the commelina yelloW mottle virus (CYMV), 
(Medberry et al., 1992); the cauli?oWer mosaic virus 
(CaMV), (LaWton et al., 1987; Odell et al., 1985); the soya 
bean chlorotic mottle virus (SoyCMV), (HasegaWa et al., 
1989); the ?gWort mosaic virus (FMV, strain DxS) (GoWda 
et al., 1989, Malti et al., 1997); FMV strain M3 (Sanger et 
al., 1990); the cassava vein mosaic virus (CVMV), 
(Verdaguer et al., 1996), and the peanut chlorotic streak 
virus (PC1SV), (Maiti and Shepherd, 1998). 
Mirabilis mosaic virus (MMV), a member of the genus 
caulimovirus, has a circular double-stranded DNA genome 
of about 8 kb pairs With four single-stranded discontinuities 
in the DNA, one in the ot-strand and three in the comple 
mentary strand (Richins and Shepherd, 1983). It infects 
Mirabilis plant species (family Nyctaginaceae) generally 
found in Warm parts of North America. The MMV Was 
characteriZed as a member of caulimovirus based upon 
morphology of its virions and inclusion bodies (Brunt and 
Kitajima, 1973). MMV is serologically distinct from cauli 
?oWer mosaic virus, the type member of the genus (Brunt 
and Kitajima, 1973). The restriction enZyme map of the 
MMV genome is also quite different than that of other 
members of this genus (Richins and Shepherd, 1983). 
SUMMARY OF THE INVENTION 
The present invention is an MMV FLt promoter DNA 
sequence that can be used to direct and express selected 
foreign genes in plant cells and plants to confer useful 
properties therein. The present invention thus provides the 
isolation and characteriZation of the full length transcript 
(FLt) promoter from mirabilis mosaic caulimovirus. 
The present invention is also optimal portions of the 
MMV FLt promoter DNA sequence that permit maximum 
promoter activity. In accordance With this embodiment, the 
present invention provides a 360 bp fragment (sequence 
—297 to +63 from the transcription start site (SEQ ID NO:4)) 
of the MMV FLt promoter DNA sequence. 
The present invention is also the use of the MMV FLt 
promoter DNA sequence or optimal portions thereof in the 
US 6,420,547 B1 
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form of a single sequence or in the form of multiple 
enhancer domains to express chimeric genes in plant cells 
and plants. The present invention is thus a chimeric gene 
construct containing the MMV FLt DNA sequence or a 
functional equivalent thereof (i.e., fragments thereof capable 
of promoter activity) in the form of a single MMV FLt DNA 
sequence or multiple enhancer domains of the MMV FLt 
DNA sequence and a coding sequence for a protein of 
interest; an expression vector containing the chimeric gene 
construct; a plant cell transformed With the chimeric gene 
construct; a plant seed transformed With the chimeric gene 
construct; a plant tissue transformed With the chimeric gene 
construct; and a transgenic plant transformed With the chi 
meric gene construct. 
The present invention is also the use of the MMV FLt 
promoter DNA sequence, a functional equivalent thereof, in 
the form of a single sequence or multiple enhancer domains 
thereof, in combination With other promoters, e.g., FMV, 
PC1SV and CaMV 35S, having nonhomologous sequences 
to introduce tWo or more proteins of interest into plants and 
plant cells. The use of promoters having nonhomologous 
sequences avoids genetic instability due to recombination 
betWeen identical promoter sequences. 
The present invention is also the transcription start site 
(TSS) of the MMV FLt promoter as determined by primer 
extension analysis using total RNA isolated from transgenic 
plants containing a MMV promoter1uidA fusion gene. 
Analysis of the 5‘ and 3‘ deletion constructs shoW that an 
upstream region (sequence —248 to —193 from the transcrip 
tion start site (SEQ ID NO12)) is very important for the 
MMV FLt promoter activity along With as-1, TATA box 
regions. In addition, the present invention is a 31 bp 
sequence (+33 to +63 from the transcription start site (SEQ 
ID NO:3)) located doWnstream of a TATA box that provides 
for the maximum expression of the MMV FLt promoter. 
Additional advantages of the present invention Will be set 
forth in the description and examples that folloW, or may be 
learned from practicing the invention. These and other 
advantages may be realiZed and attained by means of the 
features, instrumentalities and/or combinations particularly 
described herein. It is also to be understood that the fore 
going general description and the folloWing detailed descrip 
tion are only exemplary and explanatory and are not to be 
vieWed as limiting or restricting the invention as claimed. 
The invention itself, together With further advantages, Will 
best be understood by reference to the folloWing detailed 
description, taken in conjunction With the accompanying 
draWings. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The patent or application ?le contains at least one draWing 
executed in color. Copies of this patent or patent application 
publication With color draWing(s) Will be provided by the 
Of?ce upon request and payment of the necessary fee. 
FIG. 1 shoWs the DNA sequence of the full length 
transcript promoter from mirabilis mosaic virus (MMV) in 
the 5‘ to 3‘ direction (SEQ ID NO: 1). The TATA-box 
(TATATAA), the CAT-box (CAAT), the polyA signal 
(AATAAA) are shoWn in bold; all the repeat sequence 
domains including as-1 and as-2 motifs listed in Table 1 
(beloW) (Designated domains: 1a, 1b; 2a, 2b; 3a, 3b; 4a, 4b; 
5a, 5b; 6a, 6b; 7a, 7b; 8a, 8b; 9a, 9b; 10a, 10b (SEQ ID 
N016); 11a, 11b, 11c; 12a, 12b; 13a, 13b; 13a, 13b, 13c; 14a, 
14b; 15a, 15b (SEQ ID N017); 16; 17; 18; 19a, 19b (SEQ ID 
N018); 20a, 20b & 20c (SEQ ID NO19)) are underlined or 
overlined. The end points for the 5‘ or the 3‘ deletion 
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plasmids are indicated above or beloW the sequence respec 
tively. The transcription start site (TSS) is indicated as +1. 
FIG. 2A shoWs a schematic map of the GUS constructs 
(number 1 to 16 (SEQ ID N01 11 THROUGH SEQ. ID. 
NO: 26)) developed for 5‘ and 3‘ deletion analysis of MMV 
FLt promoter. The coordinates of the relative deletion frag 
ment are indicated in the parenthesis. At the bottom, the 
relative positions of the TATA-box, CAAT box, transcription 
starts site (+1) and direct repeats sequences (listed in Table 
1, numbered in circle) are shoWn. 
FIG. 2B shoWs an MMV FLt promoter deletion analysis 
in transgenic plants expressing the GUS reporter gene. 
Expression analysis of 5‘- and 3‘-end deletion constructs (# 
1 to 16 (SEQ ID N01 11 THROUGH SEQ ID N01 26)) of 
the MMV FLt promoter in transgenic N. tabacum cv Samsun 
NN (R1 progeny, 24-day-old seedlings) Was conducted. The 
5‘- and 3‘-deletion end points for each construct are as 
indicated in FIG. 2A. The MMV promoter activity Was 
monitored in 24-day-old seedlings (R1 generation, KanR) 
groWn aseptically on an MS-agar medium in the presence of 
kanamycin (200 mg/ml) and 3% sucrose. Soluble protein 
extracts (5 pg) from Whole seedlings Were used for GUS 
assay. The data are means of four independent experiments 
for each construct (#1 to 16 (SEQ ID N01 11 THROUGH 
SEQ ID N01 26)); eight to ten independent lines for each 
construct Were assayed. The average GUS activity is pre 
sented for each chimeric construct in the histogram With the 
standard deviation from the mean indicated by an error bar. 
Error bars shoW the 95% con?dence intervals on the means. 
The statistical (One-Way Analysis of Variance, ANOVA) 
analysis shoWed the P value<0.0001, considered extremely 
signi?cant. (C) Untransformed control, tissue extract from 
Wild type N. tabacum cv Samsun NN. (35S) GUS gene 
directed by the CaMV 35S promoter. 
FIG. 2C shoWs an MMV FLt promoter deletion analysis 
in protoplast transient expression experiments. The average 
GUS activity from three independent experiments is pre 
sented for each construct in the histogram With the standard 
deviation from the mean indicated by an error bar. Error bars 
shoW the 95% con?dence intervals on the means. The 
statistical ANOVA analysis shoWed the P value<0.0001, 
considered extremely signi?cant. 
FIG. 3 shoWs histochemical analysis of GUS expression 
in tobacco seedlings (transgenic N. tabacum cv Samsun NN, 
R1 progeny, 24-day-old seedlings) from the best expressing 
independent line representing each construct # 1 to 16 (SEQ 
ID N01 11 THROUGH SEQ ID N01 26) containing the 
GUS gene driven by the designated MMV FLt promoter 
fragment. These data Were derived from pools of trans 
formed lines in each construct. The upstream and doWn 
stream deletion end points for each construct are as indicated 
in FIG. 2A. 
(Numbers 1 to 16 (SEQ ID NO111 THROUGH SEQ ID 
NO126)) shoWs histochemical localiZation of GUS activity 
in transgenic tobacco seedlings (magni?cation X10) repre 
senting each construct #1 to 16 (SEQ ID NO111 THROUGH 
SEQ ID NO126), respectively. GUS staining Was most 
intense With construct # 12 (SEQ ID NO122) folloWed by 
construct # 13 (SEQ ID NO123) and #11 (SEQ ID NO121). 
Construct #10 (SEQ ID NO120), devoid of TATA box, 
shoWed no GUS activity and construct #8 (SEQ ID NO118), 
devoid of upstream sequence (—133 to —193), shoWed very 
little GUS activity. (#17) Untransformed control, Wild type 
N. tabacum cv Samsun NN 24-day-old seedling 
(magni?cation X10), no GUS activity Was detected. 
FIG. 4(A) shoWs RNA-dot hybridiZation analysis of total 
RNA (10 pg) isolated from 24-day-old seedlings developed 
US 6,420,547 B1 
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for each construct # 1 to 16 (SEQ ID NO: 11 THROUGH 
SEQ ID NO: 26). Total RNA Was isolated from the best 
GUS-expressing independent line. 
FIG. 4(B) shows Northern analysis of total RNA isolated 
from untransformed Samsun NN (lane 1) and transgenic 
tobacco seedlings (R1 progeny) developed With construct 
#12 (SEQ ID NO:22), (lane 2). Total RNA Was hybridized 
With 32P-labeled GUS coding sequence. 
FIG. 5 shoWs construction strategy for duplicating 
enhancer domains of the MMV FLt promoter. The EcoRI 
(E), HindIII (H), SmaI (S) and HincII (Hc) restriction sites 
used for cloning, and the relative position of TATA sequence 
are shoWn. In pUM24 and pUM26, SmaI and HincII sites 
(SmaI/HincII) are modi?ed. 
FIG. 6 shoWs a schematic representation of GUS con 
structs used for analyZing expression of the MMVFLt and 
CaMV 35S promoters in transgenic plants. The respective 
promoter for each construct is presented. The position of 
restriction sites used to assemble these expression constructs 
are shoWn; GUS represents the gene for the [3-glucuronidase 
of E. coli. The left and right T-DNA border (LB and RB 
respectively), the rbcS and Nos polyadenylation signal 
(Terminators) and the KanR genes are illustrated. 
FIGS. 7(A) and 7(B) shoW comparative expression analy 
sis of the CaMV 35S and the MMV FLt promoters With 
single and duplicated enhancer domains, in transgenic plants 
of N. tabacum cv. Samsun NN (R1 progeny). FIG. 7(A) 
shoWs a comparison of the CaMV 35S promoter in construct 
pKYLX71GUS and MMV FLt promoter in constructs 
pKM1GUS, pKM12GUS and pKM13GUS, directing the 
GUS reporter gene. GUS activity is determined in tissue 
extract of 24-days-old seedlings (R1 progeny/second 
generation). Seedlings are groWn in presence of kanamycin 
(200 mg/ml). The 5‘ and 3‘ ends of each MMV FLt promoter 
in pKM1GUS, pKM12GUS and pKM13GUS are shoWn in 
parentheses (—457 to +133 (SEQ ID NO:11)) (—297 to +63 
(SEQ ID NO:22)) and (—248 to +63 (SEQ ID NO:23)) 
respectively. At least tWelve independent lines Were gener 
ated for each construct. The presented value is the meaniSD 
of three samplings from each of eight independent lines 
developed for each construct. The MMV FLt promoter 
activity is signi?cantly different (P<0.0001) from the value 
observed for the CaMV 35S promoter. FIG. 7(B) shoWs a 
comparison of Wild type and modi?ed MMV FLt promoter 
activity in independent transgenic plants of Nicotiana [aba 
citin cv. Samsun NN (24-days-old seedlings, R1 progeny/ 
second generation) expressing a GUS reporter gene. At least 
tWelve independent lines Were generated for the folloWing 
GUS-constructs: pKM12GUS and pKM13GUS With the 
Wild type MMV FLt promoter containing a single enhancer 
domain, and pKM24GUS and pKM26GUS With a modi?ed 
MMV FLt promoter containing duplicated enhancer 
domains. The presented value is the mean of three sampling 
from each of eight independent lines developed for each 
construct; average GUS activity is presented as the histo 
gram With the standard deviation from the mean indicated by 
an error bar. The tWo-tailed P value for pKM12GUS Vs 
pKM24GUS, and pKM13GUS Vs pKM26GUS is 0.0027 
and 0.0079, respectively, is considered very signi?cant. 
FIGS. 8(A) and 8(B) shoW expression activity of MMV 
FLt promoter in various parts of seedlings and different 
?oWer organs. FIG. 8(A) shoWs the MMV FLt promoter 
activity in different parts of transgenic tobacco seedlings (N. 
tabacum cv Samsun NN, 24-days-old) as assayed by mea 
suring GUS activity in tissue extracts of roots (R), stems (S) 
and leaves (L) of seedlings developed for the folloWing 
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constructs: pKM1GUS, pKM12GUS and pKM13GUS. The 
presented value is the average of seven samplings from each 
of eight independent lines developed for each construct; 
variation Was Within 30% of the presented value. FIG. 8(B) 
shoWs MMV FLt promoter activity in different ?oral organs. 
GUS activity Was measured in each tissue extract as indi 
cated. Tobacco ?oWers, one day before anthesis, Were 
sampled from transgenic tobacco plants (R0 progeny) devel 
oped for the construct pKM12GUS expressing the GUS 
gene directed by MMV FLt promoter (—297 to +63 (SEQ ID 
NO:22)). Each sample Was assayed four times in three 
independent experiments. The average GUS activity is pre 
sented in the histogram; the variation Was Within 25% of the 
presented value. 
FIGS. 9(A)—9(K) shoW histochemical localiZation of 
GUS activity in developing transgenic tobacco plants 
expressing the GUS reporter gene directed by MMV FLt 
promoter. All sections are at 15x magni?cation. 
FIG. 9(A) shoWs mature leaf section from six-Week-old 
plants (R1 progeny) developed for construct pKM12GUS; 
note more GUS staining in vascular tissue (v), midrib and 
veins. 
FIG. 9(B) shoWs root from four-Week-old seedlings 
(pKM12GUS, R1 progeny), staining is most intense at the 
tip and in vascular tissue. 
FIGS. 9(C), 9(D), and 9(E) shoW transverse stem section 
(C), and longitudinal stem section (E), from four-Week-old 
seedlings (pKM12GUS, R1 progeny); GUS activity local 
iZed mostly in vascular (v) tissues. No GUS activity With 
non-transformed control transverse stem 
FIG. 9(F) and FIG. 9(G) shoW transverse section of 
petiole (F), from four-Week-old seedlings (pKM12GUS, R1 
progeny), GUS staining is most intense in the vascular (v) 
system. Transverse section of petiole (G), from four-Week 
old non-transformed Samsun NN seedlings, no GUS stain 
ing Was detected. 
FIG. 9(H) shoWs transgenic tobacco seedlings 
(pKM12GUS, R1 progeny) at 6 DAI groWn axenically on 
agar plate, GUS activity is localiZed primarily in the root, 
root tip and loWer hypocotyl. 
FIG. 9(I) shoWs transverse section of tobacco ovary: 
ovule (ov) and placenta (P) are stained most intensely. 
FIG. 9(J) shoWs anther, and 9(K) shoWs ?oWer tissue; the 
style and the petal display GUS staining. 
DETAILED DESCRIPTION OF THE 
INVENTION 
All patents, patent applications and literatures cited in this 
description are incorporated herein by reference in their 
entirety. 
As used throughout this application, SEQ ID NO:4 and 
SEQ ID NO:22 are interchangeably used because they 
identify identical sequences. 
As used throughout this application, SEQ ID NO:4 and 
SEQ ID NO:22 are interchangeably used because they 
indentify indentical sequences. 
The present invention is the identi?cation and character 
iZation of the full-length transcript (FLt) promoter (SEQ ID 
NO:1) from the mirabilis mosaic virus (MMV), a neWly 
described member of the caulimovirus group. The short 
segment of the viral genetic material (MMV FLt promoter 
sequence) used in this invention does not infect plants or 
other organisms to cause disease. The DNA sequence is thus 
useful to direct and express selected foreign genes in plants 
to confer useful properties to transgenic plants. 
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The optimal boundaries required for maximum promoter 
activity are de?ned by the 5‘- and 3‘-end deletion analysis of 
promoter/leader region of the full-length transcript promoter 
of MMV in transgenic tobacco plants. A 360 bp MMV FLt 
promoter fragment (sequence —297 to +63 from transcrip 
tion start site (SEQ ID NO:22)) is suf?cient for strong 
constitutive promoter activity. In a comparative expression 
analysis, the MMV FLt promoter is found to be approxi 
mately 15 to 24 times stronger than the CaMV 35S promoter. 
The patterns of MMV FLt-directed GUS gene expression 
are analyZed in transgenic seedlings and matured plants at 
various stages of development. Plant expression vectors are 
adapted With the MMV FLt promoter having single and 
duplicated enhancer domains. The duplication of the 
upstream enhancer domains increases the promoter activity 
by at least 2 to 3 fold. In plant metabolic engineering Where 
multiple genes need to be expressed in a single cell, the use 
of a different promoter With a non-homologous sequence is 
useful in order to avoid genetic instability due to recombi 
nation betWeen identical promoter sequences. Promoters 
from other member of the caulimovirus group such as MMV, 
FMV, PC1SV as Well as the CaMV 35S promoter are thus 
very effective in plant genetic engineering applications. 
Plant genetic engineering techniques alloWs researchers 
to introduce heterologous genes of interest into plants cells 
to obtain the desired qualities in the plants of choice (Maiti 
and Hunt, 1992; Wagner, 1992). Plant biotechnology is 
leading a rapid progress in the production of economically 
valuable germplasm With improved characteristics or traits 
such as insect resistance, virus resistance, fungal resistance, 
herbicide resistance, bacterial or nematode pathogen 
resistance, cold or drought tolerance, improved nutritional 
value, seed oil modi?cation, delayed ripening of fruit, and 
male sterility, to name a feW. These germplasms provide 
enhanced development in breeding programs for crop 
improvement as Well as a better understanding of gene 
regulation and organiZation in transgenic plants. The expres 
sion of useful foreign traits in plants is a major focus in plant 
biotechnology. 
Plant metabolic engineering is the application of genetic 
engineering methods to modify the nature of chemical 
metabolites in plants. For metabolic engineering Where 
multiple genes need to be inserted into one cell, the use of 
different strong constitutive promoters is desirable in order 
to avoid genetic instability caused by recombination 
betWeen identical or closely related promoter sequences, for 
example, those taken from plants themselves. Through use 
of these promoter sequences, the introduced genes can be 
transcribed to messenger RNA and then translated to result 
ant proteins to exhibit neW traits or characteristics. 
Besides developing useful traits in crops, plant metabolic 
engineering provides further understanding of molecular 
pathWays involved in disease development and secondary 
metabolism in plants. Moreover, by engineering plants With 
speci?c foreign genes, the responses of plants to abiotic and 
biotic stress and stress related metabolism can be analyZed. 
The present invention, Which involves developing gene 
vectors With neWly de?ned promoters of the caulimoviruses, 
advances this effort. 
A Wide variety of Well-characterized genes of animal, 
human, bacterial and plant origin, including those of several 
viruses, are available for engineering plants. For the most 
effective expression of this Wide selection of genes either 
constitutive or regulated, versatile gene expression vectors 
are required. At the University of Kentucky, Dr. Arthur Hunt 
and his colleagues have developed a series of plant expres 
sion vectors (Schardl, et al., 1987) With a constitutive 35S 
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promoter from cauli?oWer mosaic virus (CaMV), Which 
have been successfully used to produce transgenic plants 
(Maiti et al., 1988, 1989, 1991, 1991a, 1992, 1992a, 1993, 
1994, 1995, 1995a; Graybosh, et al., 1989; Berger, et al., 
1989; Yeargan, et al., 1992; Liod, et al., 1992). In accordance 
With the present invention, useful promoters from MMV for 
high level expression of foreign genes in transgenic plants 
are developed. These vectors are useful for both direct DNA 
uptake by isolated protoplasts and Ti plasmid-mediated gene 
transfer. 
Enhanced levels of transcription via highly active pro 
moters are essential for high levels of gene expression. The 
most Widely used promoter for plant transformation, as 
described earlier, has been the 35S promoter of CaMV. It is 
active in a Wide variety of plants and tissues. It is also the 
most thoroughly characteriZed promoter With respect to the 
sequence elements active in its transcriptional activity. 
(Benfey and Chua, 1990). Kay, et al., 1987 shoWed that the 
transcriptional activity of the CaMV 35S promoter could be 
increased approximately 10-fold by making a tandem dupli 
cation of 250 base pairs of upstream sequence. Similar 
observations have been made With other promoters 
(McNeall, et al., 1989). Earlier, the present inventors con 
structed and tested a similar construct With the full-length 
transcript promoters from FMV (Maiti et al., 1997; US. 
patent application Ser. No. 08/675,090, now US. Pat. No. 
5,994,521), and from PC1SV (Maiti and Shepherd, 1998; 
US. Pat. No. 5,850,019). 
The Monsanto Co. has recently patented the 35S and the 
19S promoters of CaMV (US. Pat. Nos. 5,352,605 and 
5,530,196, respectively) and the full length transcript pro 
moter from FMV (US. Pat. No. 5,378,619). 
A conventional gene of DNA is composed of a promoter 
region, a 5‘ non-translated leader sequence of the transcribed 
messenger RNA, the structural gene itself and a 3‘ polyade 
nylation sequence. The promoter is a DNA fragment com 
posed of modular sequence Which directs and regulates the 
transcription to messenger RNA, the ?rst step in expression 
of a gene. The proper regulatory signals/enhancer elements 
must be present in a de?ned location in order to express the 
inserted gene ?rst into RNA and then into a resultant protein 
via the process of translation. The 3‘-polyadenylation 
sequence is a non-translated region Which signals the ade 
nylation of the 3‘ end of the RNA in order to stabiliZe the 
RNA in the cytoplasm for subsequent translation into pro 
tein. 
Certain promoters have a speci?c modular sequence, 
Which makes them either tissue speci?c, developmentally 
regulated or environmentally regulated for selective expres 
sion of genes in cells. Promoters capable of directing RNA 
synthesis at higher rates compared to other promoters are 
desirable for many purposes. Each promoter has a different 
DNA sequence and is hence unique. Consequently, it Will 
exhibit different activities (strength) under a variety of 
conditions and circumstances from other promoters. Pro 
moters that are able to direct the expression of genes in most 
types of tissues in plants are de?ned as constitutive promot 
ers. Previous Work established that the CaMV 35S promoter 
is one of the strongest constitutive promoters. The transcrip 
tional activity of the CaMV 35S promoter is the result of a 
synergistic and combinatorial effect of enhancer elements 
residing upstream of the TATA element. Single or multiple 
copies of the enhancer sequences from the CaMV 35S 
promoter can also increase the activity of heterologous 
promoter in an orientation-independent manner. The 
enhancement of promoter activity relates to the copy number 
of the enhancer sequence. 
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The present invention relates to promoters from mirabilis 
mosaic virus (MMV) and the use thereof to direct the 
expression of genes in plant cells and plants. 
The present invention includes expression vectors con 
taining the MMV promoter With its single and duplicated 
enhancer domains. The upstream enhancer elements of the 
strong constitutive promoter from the full length transcript 
of MMV is doubled in a strategy to strengthen the promoter 
even further. 
An objective of the present invention is to de?ne and 
document the strong constitutive FLt promoter of MMV to 
be used for expression of chimeric genes in transgenic 
plants. A further object is to describe a strategy to further 
strengthen the promoter for the full-length transcript of other 
member of the caulimoviruses including MMV. 
The present invention thus includes the folloWing: i) the 
isolation and mapping of the promoter for the full length 
transcript (FLt) from mirabilis mosaic virus from a full 
length viral DNA clone; ii) the modi?cation, including the 
duplication or multimeriZation of the enhancer domain of 
the FLt promoter from the MMV; and iii) the use of the 
MMV FLt promoter in a method for transforming plant cells 
With the expression vectors created With Wild type and 
modi?ed MMV FLt promoters directing chimeric genes in 
transgenic plants, plant tissues, plant cells and plant seeds 
and their progeny. 
Experimental Procedures 
Isolation of MMV FLt promoter fragments and construction 
of plant expression vectors 
The plasmid pMMV-B10, a full-length genomic clone of 
MMV (Richins and Shepherd, 1983) has been fully 
sequenced (Maiti, 1996, unpublished data). A 590 bp seg 
ment (coordinates 6621 to 7210 of the MMV genome) Was 
selected for MMV promoter deletion analysis. A series of 
promoter fragments included in constructing the plant trans 
formation vector With the MMV FLt promoter Were 
designed to study the in?uence of the upstream and doWn 
stream repeat sequences With respect to the TATA-box. The 
de?ned MMV FLt promoter sequence, of length as indicated 
(see in FIG. 2A) Was ampli?ed by PCR using appropriately 
designed oligonucleotides to tailor EcoRI at the 5‘-end and 
HindIII sites at the 3‘-end positions. The plasmid pMMV 
B10, a genomic DNA clone of MMV (Richins and 
Shepherd, 1983) Was used as template for PCR reaction. 
PCR ampli?cation Was carried out for 30 cycles under the 
folloWing standard condition; denaturation (92° C. for 1 
min), annealing (55° C. for 1 min), synthesis (72° C. for 2 
min) using recombinant TaqDNA polymerase (GIBCO 
BRL). Each of these appropriately siZed PCR-generated 
MMV promoter fragments # 1 to 16 (SEQ ID NO: 1 
THROUGH SEQ ID NO: 26) Was restricted With EcoRI and 
HindIII, the restricted fragment Was gel puri?ed and cloned 
into the corresponding sites of pUC119 for DNA sequenc 
ing. Before use, all PCR products cloned into pUC119 Were 
sequenced by dideoxy chain terminator method (Sanger et 
al., 1997) using synthetic primers. Subsequently the pro 
moter fragments Were isolated after restriction from pUC119 
plasmids. Each of these promoter fragments Was gel puri?ed 
and cloned into the plant expression vector pKYLX 71 
(Schardl et al., 1987) at its unique EcoRI and HindIII sites 
that ?ank the promoter. The folloWing deletion plasmids 
Were developed; the 5‘- and 3‘ ends of the promoter frag 
ments are given in parenthesis: pKM1 (—457 to +133 (SEQ 
ID NO:11)), pKM2(-418 to +133 (SEQ ID NO:12)), pKM3 
(—378 to +133 (SEQ ID NO: 13)), pKM4 (—340 to +133 
(SEQ ID NO: 14)), pKM5 (—297 to +133 (SEQ ID NO:15)), 
pKM6 (—248 to +133 (SEQ ID NO:16)), pKM7 (—193 to 
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+133 (SEQ ID NO: 17)), pKM8 (—133 to +133 (SEQ ID 
NO:18)), pKM9 (—78 to +133 (SEQ ID NO: 19)), pKM10 
(—297 to —38 (SEQ ID NO:20)), pKM11 (—457 to +63 (SEQ 
ID NO:21)), pKM12 (—297 to +63 (SEQ ID NO:22)), 
pKM13 (—248 to +63 (SEQ ID NO:23)), pKM14 (—193 to 
+63 (SEQ ID NO:24)), pKM15 (—297 to +2 (SEQ ID NO: 
25)) and pKM16 (—287 to +33 (SEQ ID NO: 26)). These 
plant expression vectors have multiple cloning sites (MCS): 
5‘-HindIII—BamHI-XhoI-SstI-XbaI-3‘) With the folloWing 
unique sites: HindIII, XhoI, SstI and XbaI. The reporter 
GUS gene Was tailored by PCR to include just the coding 
sequence With the initiation and termination codons, ?anked 
by a XhoI site at the 5‘ end and a SstI site at the 3‘ end. The 
PCR isolated fragment for the GUS reporter gene Was 
digested With XhoI and SstI, gel puri?ed and cloned into the 
corresponding sites of the pBS(KS+); the resulting plasmid 
Was named pBSGUS. The GUS gene in pBSGUS Was fully 
sequenced before use. The GUS gene from pBSGUS as 
XhoI-SstI fragment Was inserted into the above mentioned 
pKYLX-based plant expression vectors and the resulting 
deletion plasmids (constructs # 1 to 16 (SEQ ID NO: 11 
THROUGH SEQ ID NO: 26) in FIG. 2A) Were designated 
as pKMlGUS, pKM2GUS, pKM3GUS, pKM4GUS, 
pKM5GUS, pKM6GUS, pKM7GUS, pKM8GUS, 
pKM9GUS, pKM10GUS, pKM11GUS, pKM12GUS, 
pKM13GUS, pKM14GUS, pKM15GUS and pKM16GUS, 
respectively. The XhoI-GUS-SstI fragment from pBSGUS 
Was inserted into the corresponding sites of pKYLX71 
(Schardl et al., 1987). The resulting plasmid pKYLX71 GUS 
contains the GUS gene directed by the CaMV35S promoter. 
Construction of Plasmids for Transient Expression in Pro 
toplasts 
The folloWing fragment: 5‘-EcoRI-CaMV 35S.2 
Promoter-HindIII-BamHI—XhoI-PstI-SstI-XbaI rbcS 3‘ 
terminator-ClaI-3‘ Was isolated from pKYLX7135S.2 
(Schardl et al., 1987) and cloned into the EcoRI and AccI 
sites of the pUC119AH (a modi?ed pUC119 in Which the 
unique HindIII site Was destroyed by digesting With HindIII, 
and ?lled With KlenoW folloWed by ligation). The resulting 
plasmid Was named pUCPMA. The GUS reporter gene from 
pBSGUS as XhoI and SstI fragment Was inserted into the 
corresponding sites of pUCPMA to generate the plasmid 
pUCPMAGUS. The MMV FLt promoter fragments Were 
cloned into the unique EcoRI and HindIII sites of transient 
expression vector pUCPMAGUS that ?anks the promoter. 
The resulting PUC-based deletion plasmids (corresponding 
construct # 1 to 16 (SEQ ID NO:11 THROUGH SEQ ID 
NO:26 in FIG. 2A) Were designated as pPM1GUS, 
pPM2GUS, pPM3GUS, pPM4GUS, pPM5GUS, 
pPM6GUS, pPM7GUS, pPM8GU, pPM9GUS, 
pPM10GUS, pPM11GUS, pPM12GUS, pPM13GUS, 
pPM14GUS, pPM15GUS, pPM16GUS, respectively. 
EXAMPLE 1 
Expression Analysis of the MMV FLt Promoter Deletion 
Constructs in Transgenic Plants and in Protoplast Transient 
Expression Experiments 
A deletion analysis scheme is shoWn in FIG. 2A. A series 
of 5‘- and 3‘-end-deleted promoter fragments Were included 
in constructing the plant transformation vector With the 
MMV FLt promoter in order to de?ne the boundaries 
required for maximal expression from the promoter/leader 
region and also to study the in?uence of the upstream and 
doWnstream repeat sequences With respect to the TATA-box. 
The de?ned MMV promoter fragments # 1 to 16 (SEQ ID 
NO: 11 THROUGH SEQ ID NO: 26) (as indicated in FIG. 
2A) Were ampli?ed by PCR and cloned into plant expression 
vector as described in Experimental Procedures. The result 
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ing plasmids contain the de?ned promoter sequences # 1 to 
16 (SEQ ID NO: 11 THROUGH SEQ ID NO: 26) as 
described in FIG. 2A. The upstream and downstream dele 
tion end points of the promoter fragment in each plasmid are 
indicated in parenthesis (FIG. 2A). The various constructs 
With a reporter gene inserted into the multiple cloning 
clusters (GUS gene in this case) Were tested in transgenic 
plants (R0 and R1 progeny) and also in protoplast transient 
expression assay. 
At least 10 to 12 independent primary transgenic tobacco 
(Nicotiana tabacum cv Samsun NN) lines (R0 progeny) 
Were generated With each of these constructs # 1 to 16 (SEQ 
ID NO: 11 THROUGH SEQ ID NO: 26), and construct 
pKYLX71 GUS (FIG. 2A). Seeds Were collected from 
self-fertiliZed independent lines. Segregation analysis of the 
marker gene (KanR) Was performed. Individual transgenic 
tobacco lines shoWing expected segregation ratio (KanR: 
KanS=3:1) for the marker KanR gene Were further analyZed. 
Eight to ten independent lines for each construct shoWed the 
expected segregation ratio. The expression of the GUS 
reporter gene in seedlings (R1 progeny/second generation) 
With these constructs (FIG. 2(A)) Was examined by ?uoro 
metric assay of tissue extracts (FIG. 2B) and in protoplast 
transient expression (FIG. 2(C)). Histochemical GUS stain 
ing (FIG. 3) examined the tissue distribution of GUS activity 
in seedlings (R1 progeny/second generation) developed With 
these constructs. 
The MMV FLt promoter deletion analysis in transgenic 
plants (FIG. 2B) and in protoplast transient expression assay 
(FIG. 2C) shoWed overall a very similar pro?le. HoWever 
the GUS activity in protoplast assay is about 200 to 800 
times less compared to stably transformed transgenic lines 
(R1 progeny). Analysis of transgenic lines (R1 progeny) and 
transient expression assay shoWed more GUS activity With 
construct #12 (SEQ ID NO:22) Which contains the promoter 
fragment (coordinate —297 to +63 from TSS, FIG. 1). In 
transgenic plants the 5‘-deletion analysis of MMV FLt 
promoter fragment # 1 to 9 (SEQ ID NO: 11 THROUGH 
SEQ ID NO: 19) (FIG. 2A) gave 54%, 47%, 36%, 42%, 
47%, 37%, 7.5%, 2.2%, and 4%, respectively, of full activity 
(compare With construct #12 (SEQ ID NO:22) giving the 
highest activity, FIG. 2B). Similarly in protoplast transient 
expression experiments the 5‘ deletion fragments # 1 to 9 
(SEQ ID NO: 11 THROUGH SEQ ID NO: 19) shoWed 23%, 
22%, 21%, 20%, 24%, 14.5%, 11%, 13.6%, and 21.8% of 
full activity, respectively (compare With construct #12 (SEQ 
ID NO:22) giving the highest activity, FIG. 2C). 
The construct #10 (SEQ ID NO:20), Which is devoid of 
the TATA box, shoWed very little or no GUS activity 
indicating the importance of a TATA elements in the MMV 
promoter sequence. A 360 bp MMV FLt promoter/leader 
fragment, sequence —297 to +63 from TSS (in construct #12 
(SEQ ID NO:22)) Was found to be suf?cient for maximal 
GUS expression in transgenic tobacco. The MMV FLt 
promoter With a longer upstream sequence (—457 to +133, 
construct #1 (SEQ ID NO:11)) is about 54% less active 
compared With the promoter fragment (—297 to +63, con 
struct #12 (SEQ ID NO:22)). 
The strength of the MMV FLt promoter With a GUS 
reporter gene Was evaluated by hybridiZation analysis of 
total RNA. Total RNA Was prepared from independent 
transformed tobacco seedlings (R1 progeny) developed for 
each construct # 1 to 16 (SEQ ID NO: 11 THROUGH SEQ 
ID NO: 26). Total RNA Was hybridiZed With a 32P-labeled 
DNA fragment containing the GUS coding sequence (FIG. 
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4A). The transcript level Was maximum With construct #12 
(SEQ ID NO: 22) and Was in good agreement With the GUS 
expression analysis performed by ?uorometric assay of total 
tissue extract (FIG. 2B) and also by histochemical GUS 
staining of transgenic tobacco seedlings (FIG. 3). The tissue 
speci?c expression of GUS in different parts of plants 
developed for these deletion constructs Was not quantita 
tively evaluated. The Northern analysis of total RNA iso 
lated from transgenic tobacco seedlings (R1 progeny/second 
generation), developed With construct #12 (SEQ ID NO:22), 
shoWed the expected siZe (2100 nt) of GUS transcript (FIG. 
4B). 
The deletion plasmids containing MMV FLt promoter 
fragment # 11 and 13 (SEQ ID NO: 21 AND SEQ ID NO: 
23) shoWed 62% and 88% of full activity respectively in 
transgenic plants (FIG. 2B); and the corresponding value in 
protoplast transient assay Were 57% and 70% of full activity 
(FIG. 2C; compare With construct # 12 (SEQ ID NO: 22)). 
In MMV FLt promoter deletion analysis in transgenic plants, 
the 5‘ deletion plasmid pKM14GUS (construct #14 (SEQ ID 
NO:24), promoter coordinate —193 to +63) containing ‘as-1’ 
domains and TATA-box sequence, and the 3‘ deletion plas 
mid pKM16GUS (construct # 16 (SEQ ID NO:26), pro 
moter coordinate —297 to +33) shoWed about 13% and 11% 
of full activity, respectively (compare With plasmid 
pKM12GUS, construct #12 (SEQ ID NO:22), giving the 
highest activity, FIG. 2B). The 5‘ deletion plasmid 
pKM14GUS (construct #14 (SEQ ID NO:24)) containing 
‘as-1’ domains and TATA-box sequence shoWed less activity 
suggesting dependency on additional upstream sequence 
elements. These results of MMV FLt promoter deletion 
analysis suggest that a TATA-upstream sequence (coordinate 
—297 to —193 (SEQ ID NO:10), in FIG. 1) and a TATA 
doWn-stream sequence (coordinate +2 to +63 (SEQ ID 
NO:27), in FIG. 1) may be involved in regulating function 
of the full-length transcript promoter. Several direct repeat 
sequences (# 8a & 8b; #9a & 9b; #10a & 10b (SEQ ID 
NO:6); # 11a & 11b; as denoted in FIG. 1) are present in the 
TATAupstream sequence (coordinate —297 to —193 (SEQ ID 
NO:10), in FIG. 1; and listed in Table 1). 
A 19 bp motif having strong homology With the activation 
sequence 1 (as-1) of the CaMV 35S promoter (Lam et al., 
1989) Was identi?ed in the MMV promoter at coordinate 
—64 to —46 (SEQ ID NO:5) relative to TSS. This motif is 
also found in FMV (Sanger et al., 1990) and CVMV 
Verdagur et al., 1996). This as-1 motif is able to confer 
root-speci?c expression in the CaMV35S promoter (Lam et 
al., 1989). HoWever the MMV FLt deletion construct #8 and 
#9 (SEQ ID NO:18 AND SEQ ID NO:19) containing 
putative as-1 domain shoWed no appreciable GUS staining 
in root tips of seedlings, hoWever, GUS expression is clearly 
evident in leaf regenerating meristem tissue (FIG. 3). More 
studies Will be needed to fully evaluate the function of as-1 
domain in the MMV FLt promoter. This as-1 domain plays 
a more complex role in the regulation of the promoter 
activity by acting synergistically With other cis-elements 
(Fang et al., 1989; Lam et al., 1989). It is also reported as a 
salicylic acid-responsive element (Qin et al., 1994). 
The promoter fragment —193 to +133 in construct #7 
(SEQ ID NO:17) confers much less promoter activity com 
pared to construct #6 (SEQ ID NO:16) With promoter 
coordinates —248 to +133 and construct #5 (SEQ ID NO:15) 
With promoter coordinates —297 to +133 (SEQ ID NO:15) 
(FIG. 2B). This implies that the upstream sequence —297 to 
—193 (SEQ ID NO:10) is essential for promoter activity and 
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tWo repeat sequences in this region (TTGAAGATAAGA, # 
10a and 10b in FIG. 1 (SEQ ID NO:6); and listed in Table 
1) at positions —265 to —254 and —245 to —234 may be 
important for promoter activity. More studies including 
internal deletion mapping Will be required to fully analyZe 
the importance of these sequences. 
The MMV FLt promoter gives better activity With a 
longer 3‘ untranslated region doWnstream of the promoter’s 
TATA box, extending to +63 compared With +2 and +33, 
(compare construct #15 and #16 (SEQ ID NO: 25 AND SEQ 
ID NO: 26) respectively With construct #12, FIG. 2B, FIG. 
3 and FIG. 4A). Increaeses in GUS transcript level and also 
in GUS activity suggest that the 3‘ untranslated region 
doWnstream of MMV FLt promoter’s TATA box has some 
sequence importance for initiation of transcription and con 
current translation. The MMV 3‘ untranslated region of the 
promoter may enhance transcription. It has been shoWn that 
the 3‘ untranslated viral regions from CaMV, and tobacco 
mosaic virus (TMV), (Day DoWson et al., 1993) stimulate 
the expression of a doWn stream reporter gene by enhancing 
translation. The 3‘ untranslated region of FMV (Maiti et al., 
1997) also stimulates the expression of a doWnstream gene; 
it needs to be evaluated Whether it is due to enhanced 
transcription or translation. 
TWo 18-nucleotide direct repeat sequences (#19a and 19b 
(SEQ ID NO:8) in FIG. 1; and listed in Table 1) and three 
10-nucleotide repeat sequences (#20a, 20b and 20c (SEQ ID 
NO:9) in FIG. 1) are located in the TATA-doWn-stream 
sequence, coordinates +2 to +63, (in FIG. 1; Table 1) (SEQ 
ID NO:5) of the MMV FLt promotor. These repeat sequence 
domains may have some regulatory functions. As the con 
struct pKM15GUS (construct #15 (SEQ ID NO:25), pro 
moter coordinate —297 to +2) shoWed much less activity 
than the pKM12GUS (construct #12 (SEQ ID NO:22), 
promoter coordinate —297 to +63), this indicates that the 
repeat sequences AATCGAAATCAAAA (SEQ ID NO:8) at 
positions +10 to +23 and +28 to +44 are also playing 
important roles in promoter activity. 
The comparative analysis of CaMV 35S-promoter and 
MMV FLt promoter in transgenic plants (R1 progeny) 
developed for construct pKYLX71GUS and pKM12GUS, 
respectively, shoWed that the MMV FLt promoter is about 
25 times stronger than the CaMV 35S promoter (FIG. 2B). 
Afull-length transcript promoter from the viral genome of 
mirabilis mosaic virus (MMV), a neWly described member 
of caulimovirus group (Richins and Shepherd, 1983) is thus 
characteriZed. The MMV promoter is a strong constitutive 
promoter able to direct foreign gene expression in transgenic 
plants. There is limited sequence homology betWeen the 
MMV FLt promoter and those of CaMV and other cauli 
movirus promoters although they are functionally 
analogous, Which may imply differences in the mechanisms 
of promoter regulation. Analysis of the MMV promoter 
sequence shoWs the presence of several motifs that resemble 
previously identi?ed cis elements that are implicated in 
transcriptional regulation. The presence of such motifs in the 
MMV promoter sequence could explain the pattern and 
relative strength of different promoter deletion fragments in 
transgenic plants. 
In accordance With the invention the regulatory region of 
the MMV FLt promoter and interacting nuclear factors 
involved in tissue-speci?c and constitutive expression of 
genes in plants has been studied. The CaMV 35S promoter 
is composed of several discrete organ speci?c cis-elements 
in the upstream region of the promoter (Lam, 1994). The 
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molecular analysis of the functional interactions betWeen 
speci?c cis-elements and cognate trans factor Will be essen 
tial in developing more active ‘super promoter’ and modi?ed 
tissue-speci?c promoter. 
Preparation of Plant Expression Vectors 
Construction of a MMV FLt Promoter With a Double 
Enhancer Element 
Procedures for isolating MMV FLt promoter fragments 
and construction of the plant expression vectors 
(pKMlGUS, pKM12GUS and pKM13GUS) With a MMV 
FLt promoter containing a single enhancer domain are 
described above. The MMV FLt promoter fragments Were 
ampli?ed from a full-length clone of MMV as described 
above. The construction strategy for isolating the MMV FLt 
promoter and duplicating its enhancer domains is shoWn in 
FIG. 5. The folloWing tWo MMV FLt promoter fragments of 
360 bp (—297 to +63 from the transcription start site (SEQ 
ID NO: 22)) and 311 bp (—248 to +63 (SEQ ID NO:23)) 
Were isolated after ampli?cation by PCR using oligonucle 
otides containing the appropriate sequence to generate 
EcoRI and HincII sites at the 5‘ end and a HindIII site at the 
3‘ end of the fragment. These tWo promoter fragments Were 
cloned into PUC119 as EcoRI-HindIII fragments. The 
resulting plasmids Were designated as pUM12 and pUM13, 
respectively. The TATA upstream sequence containing 
enhancer domains, a 261 bp (position —297 to —38 from the 
transcription start site (SEQ ID NO:20)) Was ampli?ed by 
PCR With oligonucleotides designed to engineer EcoRI 
HincII sites at the 5‘ end and SmaI-HindIII sites at the 3‘ end 
of the fragment. This enhancer fragment Was cloned into the 
EcoRI and HindIII sites of pUC119 and the plasmid Was 
named as pUM-enh. TWo MMV FLt promoter fragments of 
360 bp and 311 bp Were isolated as HincII-HindIII frag 
ments from pUM12 and pUM13, respectively; these frag 
ments Were inserted into the SmaI and HindIII sites of 
pUM-enh. The resulting plasmids designated as pUM24 and 
pUM26 contain tWo copies of the enhancer elements. The 
respective MMV FLt promoter With its duplicated enhancer 
domain Was inserted into the plant expression vector 
pKYLX71 (Schardl et al., 1987) at its unique EcoRI and 
HindIII sites that ?ank the promoter. The resulting expres 
sion vectors Were designated as pKM24 and pKM26, 
respectively. 
EXAMPLE 2 
Comparative Expression Analysis of the CaMV 35S Pro 
moter With the MMV FLt Promoters Containing Single and 
Duplicated Enhancer Domains 
In order to compare the relative expression activities of 
the MMV FLt promoter and the CaMV 35S promoter, We 
tested the folloWing gene constructs coupled to the GUS 
reporter gene in stably transformed tobacco plants: 
pKMlGUS, pKM12GUS and pKM13GUS for the MMV 
FLt promoter With a single enhancer domain and 
pKYLX71GUS containing the CaMV35S promoter. Asche 
matic map for each construct is shoWn in FIG. 6. At least 12 
independent primary tobacco lines Were generated for each 
construct. Transformation is carried out using Nicotiana 
tabacum cv. Samsun NN as described earlier (Maiti et al., 
1997). The integration of the reporter GUS gene in the 
genome of transgenic plants (R0 and R1 progeny) Was 
con?rmed by PCR analysis (data not shoWn). Acomparative 
analysis Was carried out by assaying the GUS activity in 
tissue extract of tobacco seedlings (R1 progeny, 24-days 
old) expressing the GUS reporter gene. Results are shoWn in 
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FIG. 7A. The pKMlGUS With the full-length MMV pro 
moter (promoter coordinates —457 to +133 (SEQ ID 
NO:11)) gave about 15 fold more expression activity com 
pared to the CaMV 35S promoter. Maximally expressing 
MMV promoter fragment in pKM12GUS With promoter 
sequence —297 to +63 (SEQ ID NO:22), shoWs about 
24-fold higher promoter expression activity compared to the 
CaMV 35S promoter. These results suggest that the MMV 
FLt promoter is relatively more stronger than the CaMV 35S 
promoter. 
EXAMPLE 3 
Expression Analysis of the MMV FLt Promoter With Single 
and Duplicated Enhancer Domains 
In order to compare the MMV Wild type and modi?ed FLt 
promoters, at least tWelve independent transgenic tobacco 
lines Were generated for each construct, pKM24GUS and 
pKM26GUS (FIG. 7B). Seedlings (R1 progeny, 24-days 
old) generated from independent lines giving a 3:1 segre 
gation ratio for the KanR marker gene Were used for GUS 
expression analysis. The MMV FLt promoter With dupli 
cated enhancer domains in constructs pKM24GUS and 
pKM26GUS shoWed 3- and 2-fold more GUS activity 
respectively compared to constructs pKM12GUS and 
pKM13GUS containing single enhancer domain (FIG. 7B). 
Hence, the MMV FLt promoter With duplicated enhancer 
domains is more active than the Wild-type promoter With a 
single enhancer domain. The duplication of enhancer 
domains sequence Was also shoWn to increase the promoter 
activity by several folds in other caulimovirus promoters 
(Kay et al., 1987; Maiti et al., 1997; Maiti and Shepherd, 
1998). 
EXAMPLE 4 
Expression of the MMV FLt Promoter in Different Parts of 
Transgenic Seedlings (R1 Progeny) 
The MMV FLt promoter activity Was examined in various 
tissues during seedling development (FIG. 8A). Seedlings 
Were groWn aseptically on an MS-agar medium in presence 
kanamycin of (200 pig/ml) and 3% sucrose. Independent 
lines shoWing 3:1 segregation ratio for the KanR marker 
gene Were taken for further analysis. Eight independent lines 
for each construct Were studied. The relative expression of 
the GUS reporter gene in 24-day-old seedlings (R1 progeny/ 
second generation) transformed With pKM12GUS or 
pKM13GUS Was monitored by ?uorometric assay of tissue 
extract and by histochemical staining of transverse section 
of leaves, stems and roots. Relative levels of GUS activity 
in roots, leaves and stems is shoWn in FIG. 8A. GUS activity 
for construct pKM12GUS Was highest in roots, about 1.5 
times more in roots compared to leaves. GUS activity Was 
very comparable in root and leaves for construct 
pKM13GUS. The loWest level of expression Was in stems 
for both construct tested. 
EXAMPLE 5 
Expression of the MMV FLt Promoter in Different Floral 
Organs 
MMV FLt promoter activity Was examined in different 
?oral organs from several primary independent lines (R0 
progeny) developed With pKM12GUS. FloWer samples 
Were collected one day before anthesis. Total soluble pro 
teins Were extracted from different parts of the ?oWer and 
subsequently GUS activity Was measured ?urometrically as 
described earlier (Maiti et al., 1997). The highest expression 
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Was observed in the pedicel folloWed by ovary, ?lament, 
petal (corolla), style, stigma and anthers (FIG. 8B). The 
activity in ?oWers is relatively loW compared to leaves, 
stems and roots of the plants. Similar observation Was made 
With the CaMV 35S promoter (An et al., 1988) and FMV FLt 
promoter (Maiti et al., 1997) in transgenic tobacco plants. 
EXAMPLE 6 
Histochemical Staining to Determine GUS Accumulation 
A detailed histochemical analysis of GUS accumulation 
shoWn in FIG. 9, Was carried out using hand-cut fresh tissue 
sections of various organs from transformed plants (R1 
progeny) developed for the construct pKM12GUS (FIG. 6). 
The vascular tissues of young leaves, petioles, roots and 
stems shoWed greatest intensity of GUS staining. The his 
tochemical GUS assay of leaves shoWed more intense 
staining in midribs, veins and other vascular tissue than in 
leaf mesophyll and palisade cells. Strong GUS accumulation 
Was detected in phloem tissues in the midrib and lateral 
secondary veins of matured leaves (FIG. 9A). Cross sections 
of stems shoWed intense staining of the phloem cells (FIGS. 
9C & 9E). The non-transformed tobacco shoWed no GUS 
activity in cross sections of vascular tissue of roots (data not 
shoWn), stems or petioles (FIGS. 9D and 9G). Intensity of 
GUS staining Was strongest in root tissues folloWed by 
leaves and stems (FIG. 9B). Histochemical GUS assay Was 
also performed With different ?oral tissues. The petal 
(corolla) portion of the ?oWer exhibited light staining (FIG. 
9K). Anther-containing pollen grains exhibited intense blue 
staining (FIG. 9]). The stigma and style portion of the ?oWer 
shoWed variation in GUS activity staining (data not shoWn). 
Pollen grains from mature anthers exhibited blue GUS 
staining (data not shoWn). The longitudinal cross-section of 
the ovary (12 days after opening of the ?oWer), shoWed 
intense blue staining of the placenta (the basal vascular part 
of the ovary) and immature seeds inside the ovary (FIG. 91). 
Differential staining intensity in different ?oral organs sug 
gests the tissue speci?city of the MMV FLt promoter. 
Afull-length transcript promoter from the viral genome of 
mirabilis mosaic virus, a member of the caulimovirus group 
(Richins and Shepherd, 1983) is thus characteriZed. The 
MMV promoter is a strong, constitutive promoter able to 
direct foreign gene expression in transgenic tobacco plants 
at a level higher than that of the CaMV 35S promoter. The 
MMV FLt promoter is highly expressed in vascular tissues 
of the stem, in leaf mesophyll cells and in root tips of 
tobacco plants. 
Plant expression vectors are adapted With the MMV FLt 
promoter With its single and duplicated enhancer domains. 
In plant metabolic engineering, Where multiple genes need 
to be expressed in a single cell, the use of different promoters 
With non-homologous sequences Will be useful in order to 
avoid genetic instability due to recombination betWeen 
identical promoter sequences. Promoters from different 
caulimovirus group such as MMV, FMV, PC1SV as Well as 
the CaMV 35S promoter are very effective in plant genetic 
engineering applications. 









